跳至主要内容
临床试验/NCT02791074
NCT02791074已完成不适用

Non-invasive Determination of Intra-left Ventricular Pressure-time Profile for Diagnosis of Heart Failure With Normal and Reduced Ejection Fraction.

National Heart Centre Singapore1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2013年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
75
试验地点
1
主要终点
First occurrence of cardiovascular event

研究概览

简要总结

This proposed study aim to:

  1. Determine intra-LV pressure-time profile non-invasively using recently developed echo Doppler VFM analysis and applanation tonometry and myocardial elastic properties, in HF subjects (both HFNEF and HFREF) compared to normal volunteers.
  2. Correlate calculated intra-LV pressure parameters with NT ProBNP levels.

详细描述

Heart failure (HF) is a common disease and its syndrome is difficult to diagnose. HF with reduced ejection fraction (HFREF) may be diagnosed based on impaired LVEF (<50%). However, diagnosis of HF with normal ejection fraction (HFNEF) is mainly based on the presence of signs and symptoms.

Central to diagnosis of HF is estimation of intra-cardiac pressure, which can only be obtained from invasive catheterization.

This proposed study aim to:

  1. Determine intra-LV pressure-time profile non-invasively using recently developed echo Doppler VFM analysis and applanation tonometry and myocardial elastic properties, in HF subjects (both HFNEF and HFREF) compared to normal volunteers.
  2. Correlate calculated intra-LV pressure parameters with NT ProBNP levels.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
21 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • has presented to hospital with a primary diagnosis of Heart Failure or
  • is attending a hospital clinic for management of Heart Failure within 6 months of an episode of decompensated heart failure, which either:
  • resulted in a hospital admission (primary diagnosis) or
  • was treated in out-patient clinic
  • LVEF >50% is used as cut-off value for HFNEF and LVEF < 50% for HFREF.
  • NT-proBNP within 7 days of admission > 220pg/ml. If there is no result available, NT-proBNP on the same day as echo scan must be > 220pg/ml.

排除标准

  • Haemodynamically significant valve disease defined as more than mild degree of valve stenosis, or more than moderate degrees of mitral or aortic valve regurgitation.
  • History of valvular disease, i.e. rheumatic heart disease and/or having undergone valvular replacement.
  • Isolated right heart failure due to pulmonary disease.
  • Presence of haemodynamically significant obstructive lesions of left ventricular outflow tract.
  • History of any organ transplant or who was on a transplant list (life expectancy < 6 months at time of enrollment).
  • Presence of end-stage renal failure.
  • Pregnancy.
  • The patient is unable to provide written informed consent.

结局指标

主要结局

First occurrence of cardiovascular event

时间窗: 1 Year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验